| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.095 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |